ChemoPalRx vs HemeOncBuddy
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ChemoPalRx
This mobile platform assists medical practitioners with safe chemotherapy prescribing. It offers a library of over 450 medications and more than 120 reference templates to generate standardized PDF prescriptions, bridging the gap for institutions without computerized order entry systems.
- Chemotherapy prescribing platform
- Reference templates
- Medication library
- Standardized PDF prescriptions
- Mobile accessibility
Read full descriptionHide full description
Safe chemotherapy prescribing remains one of the top priorities for medical institutions and practitioners. While computerized order entry system embedded in electronic health record (EHR) has been shown to enhance the safety and efficiency of chemotherapy prescribing, implementation of such system continue to be challenging for institutions that lack the financial incentives, technological capabilities, and administration buy-in to invest and implement such system. As the result, many medical institutions continue to have practitioners to hand write chemotherapy prescription for cancer patients. In an effort to bridge the gap for safe chemotherapy prescribing for institutions that lack a computerized order entry system in their EMR, ChemoPalRx was developed. ChemoPalRx is a mobile chemotherapy prescribing and reference platform for practitioners. It has over 120 build-in chemotherapy reference template and a 450+ chemotherapy medications library that allows practitioners to safely and efficiently transcribed their chemotherapy prescription into a standardized .pdf format for prescribing. Implementation of this free mobile application would allow for consistency in chemotherapy prescribing with the potential to impact patient outcomes globally.
HemeOncBuddy
This app provides quick access to practice-changing clinical trials in Hematology and Oncology. It offers simplified summaries of trial background, inclusion/exclusion criteria, primary endpoints, and outcomes for easy reference.
- Practice-changing clinical trial summaries
- Hematology and Oncology focus
- Simplified trial information
- Inclusion and exclusion criteria
- Primary endpoints and outcomes
- Quick reference tool
Read full descriptionHide full description
HemeOncBuddy is a free study hub built for hematology and oncology fellows and trainees - everything you need to keep up with the literature and prep for boards, in one fast, searchable app. WHAT'S INSIDE - 1,500+ pivotal clinical-trial summaries, each in the same structure (background, inclusion criteria, arms, primary/secondary endpoints, median follow-up, key results, notable toxicities) so you can scan them quickly. - A Question Bank with board-style questions, tutor and timed modes, explanations, and progress tracking. - ~2,000 active-recall flashcards across oncology, malignant and benign heme, and pharmacology — plus visual staging decks. - 120+ concise disease-site board-prep notes. - A conference & abstract-deadline tracker so you never miss a submission window. MADE FOR STUDYING - Full dark mode and adjustable text size. - Optional free account (Sign in with Apple, Google, or email) to sync your saved trials, Qbank progress, and notes across iPhone, iPad, and Mac. - No ads. No paywall. No login required to browse. HemeOncBuddy is an educational study aid only. It is not a substitute for medical advice, clinical judgment, or current guidelines, and must not be used to diagnose or treat patients. Always verify against primary literature and current guidelines.
Screenshots
Verdict
The clearest difference is update cadence: ChemoPalRx at every 11 days against HemeOncBuddy's every 24 months. ChemoPalRx also leads on iOS requirement (11.0 vs 15.0). HemeOncBuddy's advantage is ratings volume (18 vs 2). On price, rating, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
On the App Store both sit at effectively the same score — 5.0 for ChemoPalRx against 5.0 for HemeOncBuddy. That said, the two scores are not equally well evidenced: HemeOncBuddy has 18 ratings behind it against 2, so its average is the more settled of the two.
ChemoPalRx ships an update every 11 days, HemeOncBuddy every 24 months. The most recent releases landed on October 29, 2026 and October 24, 2026 respectively.
| Parameter | ChemoPalRx | HemeOncBuddy |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (2 ratings) | 5.0 (18 ratings) |
| Positive reviews | — | 100.0% of reviews |
| Number of ratings | 2 | 18 — better |
| Update frequency | Every 11 days — better | Every 24 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 11.0 — better | 15.0 |
| Further details — not scored | ||
| Size | 12 MB | 16 MB |
| Age rating | 17+ | 17+ |
| Developer | TeamX Health | Veli Bakalov |
Customer experience
ChemoPalRx
HemeOncBuddy
In-app purchases
ChemoPalRx
No in-app purchases
HemeOncBuddy
No in-app purchases
Questions
Is ChemoPalRx free?
Is HemeOncBuddy free?
Which has better reviews, ChemoPalRx or HemeOncBuddy?
Do ChemoPalRx or HemeOncBuddy have ads?
Which is updated more often, ChemoPalRx or HemeOncBuddy?
Other comparisons















